Natus Medical Incorporated (NTUS) Misses Q3 EPS by 1c, Revenues Miss; Q4/FY19 Revenue Guidance Below Consensus, Affirms Q4/FY19 EPS Outlook

October 24, 2019 4:41 PM

Natus Medical Incorporated (NASDAQ: NTUS) reported Q3 EPS of $0.36, $0.01 worse than the analyst estimate of $0.37. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found